Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Postmarket Surveillance Registry Evaluating the Performance and Long Term Safety of the Presillion Stent in de Novo Native Coronary Artery Lesions. Iberian Registry

NCT00968019 is registered in ClinicalTrials.gov with Johnson and Johnson, S.A. as lead sponsor.

NCT NCT00968019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00968019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Postmarket Surveillance Registry Evaluating the Performance and Long Term Safety of the Presillion Stent in de Novo Native Coronary Artery Lesions. Iberian Registry
Lead sponsor
Johnson and Johnson, S.A.
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
May 31, 2011
Enrollment
318 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arteriosclerosis